SaVida Health Company Profile

Background

Overview

SaVida Health is a healthcare services company specializing in outpatient treatment for opioid and alcohol addiction. Founded in 2010, the company is headquartered in Nashville, Tennessee, and operates multiple treatment centers across several states, including Vermont, Massachusetts, Maine, Virginia, Delaware, and Ohio. SaVida Health offers a comprehensive, patient-centric approach to addiction recovery, integrating medical care, counseling, and case management services.

Mission and Vision

SaVida Health's mission is to provide accessible, evidence-based treatment for individuals struggling with opioid and alcohol addiction. The company envisions a future where addiction is recognized as a chronic disease, not a personal failure, and where every individual has access to compassionate and effective care.

Primary Area of Focus

The company's primary focus is on outpatient medication-assisted treatment (MAT) for opioid and alcohol use disorders. SaVida Health combines FDA-approved medications with counseling and case management to support individuals in their recovery journey.

Industry Significance

SaVida Health plays a significant role in addressing the opioid and alcohol addiction crisis in the United States. By offering accessible and comprehensive outpatient treatment options, the company contributes to the broader effort of providing effective solutions for substance use disorders.

Key Strategic Focus

Core Objectives

Accessible Treatment: Provide immediate appointments and flexible scheduling to ensure timely care for individuals seeking help.

Comprehensive Care: Offer a holistic approach that includes medication, counseling, and support services under one roof.

Personalized Treatment Plans: Develop tailored treatment plans to meet the unique needs of each patient.

Continuous Support: Ensure ongoing support throughout the recovery process to promote long-term success.

Specific Areas of Specialization

Medication-Assisted Treatment (MAT): Utilize FDA-approved medications like buprenorphine-naloxone (Suboxone) and naltrexone (Vivitrol) to aid in recovery.

Counseling Services: Provide individual and group counseling to address the psychological aspects of addiction.

Case Management: Assist patients in accessing additional resources and support systems to enhance recovery outcomes.

Key Technologies Utilized

Telehealth Services: Offer virtual appointments to increase accessibility for patients unable to attend in-person sessions.

Electronic Health Records (EHR): Implement EHR systems to streamline patient information management and improve care coordination.

Primary Markets Targeted

SaVida Health primarily serves individuals in the United States struggling with opioid and alcohol addiction, focusing on communities in Vermont, Massachusetts, Maine, Virginia, Delaware, and Ohio.

Financials and Funding

Funding History

In August 2017, SaVida Health was acquired by Council Capital, a private equity firm specializing in healthcare services. Prior to this acquisition, the company had been expanding its operations, opening new treatment centers in various states to meet the growing demand for addiction treatment services.

Total Funds Raised

Specific details regarding the total funds raised by SaVida Health are not publicly disclosed.

Notable Investors

Council Capital: The private equity firm that acquired SaVida Health in 2017.

Intended Utilization of Capital

The capital from the acquisition by Council Capital has been utilized to support SaVida Health's expansion efforts, including the opening of new treatment centers and the enhancement of existing facilities to provide comprehensive care to individuals seeking recovery from opioid and alcohol addiction.

Pipeline Development

Key Pipeline Candidates

SaVida Health's pipeline primarily consists of the development and expansion of outpatient treatment centers across various states to increase access to addiction treatment services.

Stages of Clinical Trials or Product Development

As a healthcare services provider, SaVida Health does not engage in clinical trials or product development. Instead, the company focuses on the expansion and enhancement of its treatment facilities and services.

Target Conditions

The primary conditions targeted by SaVida Health are opioid and alcohol use disorders.

Relevant Timelines for Anticipated Milestones

SaVida Health continues to assess opportunities for expansion and service enhancement to meet the evolving needs of individuals seeking addiction treatment. Specific timelines for future milestones are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

SaVida Health utilizes FDA-approved medications such as buprenorphine-naloxone (Suboxone) and naltrexone (Vivitrol) as part of its medication-assisted treatment programs.

Significant Scientific Methods

Medication-Assisted Treatment (MAT): Combines FDA-approved medications with counseling and case management to support recovery.

Telehealth Services: Provides virtual appointments to increase accessibility for patients.

Electronic Health Records (EHR): Streamlines patient information management and improves care coordination.

Leadership Team

Key Executive Profiles

Andy Ward: Chief Growth Officer at SaVida Health.

Sharon Shepard: Chief Operating Officer at SaVida Health.

Dr. Suzanne Smith: Medical Director at SaVida Health's Greenfield, MA location.

Dr. Sue Cary: Medical Director at SaVida Health's Biddeford, ME location.

Professional Backgrounds and Key Contributions

Andy Ward: As Chief Growth Officer, Andy Ward has been instrumental in SaVida Health's expansion efforts, overseeing the opening of new treatment centers and the development of strategic partnerships.

Sharon Shepard: Serving as Chief Operating Officer, Sharon Shepard has played a key role in operational management and the implementation of patient-centered care initiatives across SaVida Health's facilities.

Dr. Suzanne Smith: As Medical Director in Greenfield, MA, Dr. Smith oversees clinical operations, ensuring the delivery of high-quality medical care to patients.

Dr. Sue Cary: Serving as Medical Director in Biddeford, ME, Dr. Cary is responsible for leading medical services and supporting patients in their recovery journey.

Leadership Changes

Recent Significant Changes or Appointments

Specific details regarding recent leadership changes or appointments at SaVida Health are not publicly disclosed.

Market Insights and Competitor Profile

Market Dynamics

The outpatient addiction treatment market is characterized by growing demand for accessible and comprehensive services addressing opioid and alcohol use disorders. Key trends include the expansion of telehealth services, integration of medication-assisted treatment, and a focus on holistic, patient-centered care.

Competitor Analysis

Spero Health: A leading provider of outpatient addiction treatment services, operating over 40 clinics across multiple states.

The Recovery Village: Offers comprehensive alcohol and drug rehabilitation services with multiple locations nationwide.

Acadia Healthcare: A provider of behavioral health services, including addiction treatment, with a network of facilities across the U.S.

Strategic Collaborations and Partnerships

SaVida Health collaborates with various healthcare providers, community organizations, and insurance companies to enhance service delivery and expand access to treatment. Specific details of these partnerships are not publicly disclosed.

Operational Insights

SaVida Health differentiates itself through its holistic approach to addiction treatment, integrating medical care, counseling, and case management services. The company's focus on immediate appointment availability and flexible scheduling enhances accessibility for patients. Additionally, SaVida Health accepts Medicaid, Medicare, and most major insurance plans, broadening its reach to diverse populations.

Strategic Opportunities and Future Directions

SaVida Health continues to explore opportunities for expansion into new markets and the enhancement of existing facilities to meet the evolving needs of individuals seeking addiction treatment. The company's commitment to evidence-based, patient-centered care positions it to play a significant role in addressing the ongoing challenges of opioid and alcohol addiction in the United States.